2006
DOI: 10.1002/pros.20319
|View full text |Cite
|
Sign up to set email alerts
|

Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer

Abstract: In contrast to increased expression of pro-tumorigenic genes, these results demonstrate decreased protein expression of a gene, for example, RKIP, can serve as a prognostic marker in PCa patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

13
156
4
3

Year Published

2007
2007
2018
2018

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 180 publications
(176 citation statements)
references
References 36 publications
13
156
4
3
Order By: Relevance
“…Consistent with its demonstrated inhibitory effect on Raf and NF-kB signaling, we and others have shown that the expression levels of RKIP are downregulated in a number of tumors, including highly metastatic prostate, breast and colon cancer, hepatocellular carcinoma, melanomas and insulinomas (Fu et al, 2003;Chatterjee et al, 2004;Schuierer et al, 2004Schuierer et al, , 2006Zhang et al, 2004;Hegan et al, 2005;Al-Mulla et al, 2006;Lee et al, 2006). The importance of RKIP in metastases was highlighted by the finding that restoration of RKIP expression inhibits prostate cancer metastasis in a murine model (Fu et al, 2003(Fu et al, , 2005. More recent studies have shown that RKIP is also a good prognostic marker of the pathogenesis of human prostate cancer (Fu et al, 2005) and a prognostic indicator for overall survival and disease-free survival in colorectal cancer (Al-Mulla et al, 2006).…”
mentioning
confidence: 52%
See 2 more Smart Citations
“…Consistent with its demonstrated inhibitory effect on Raf and NF-kB signaling, we and others have shown that the expression levels of RKIP are downregulated in a number of tumors, including highly metastatic prostate, breast and colon cancer, hepatocellular carcinoma, melanomas and insulinomas (Fu et al, 2003;Chatterjee et al, 2004;Schuierer et al, 2004Schuierer et al, , 2006Zhang et al, 2004;Hegan et al, 2005;Al-Mulla et al, 2006;Lee et al, 2006). The importance of RKIP in metastases was highlighted by the finding that restoration of RKIP expression inhibits prostate cancer metastasis in a murine model (Fu et al, 2003(Fu et al, , 2005. More recent studies have shown that RKIP is also a good prognostic marker of the pathogenesis of human prostate cancer (Fu et al, 2005) and a prognostic indicator for overall survival and disease-free survival in colorectal cancer (Al-Mulla et al, 2006).…”
mentioning
confidence: 52%
“…Although there was a small increase in Slug between PCA and metastasis of prostate cancer samples, the difference was not statistically significant. RKIP was recently reported as being downregulated in metastatic prostate cancer (Fu et al, 2003(Fu et al, , 2005. However, it is not known how RKIP is downregulated in cancer, or how it is transcriptionally regulated.…”
Section: Snail Is a Repressor Of Rkip Transcription S Beach Et Almentioning
confidence: 99%
See 1 more Smart Citation
“…Previous studies have described low levels of RKIP in other metastatic tumors, such as breast and colorectal carcinoma (23,45), as well as in many other primary tumors, including GISTs (27), insulinoma (22), hepatocarcinoma (24), ovarian carcinoma (26), merckel cell carcinoma (16) and thyroid carcinoma (15), cutaneous squamous cell carcinoma (46) and nasopharyngeal carcinoma (17). Furthermore, loss of cytoplasmic RKIP has also been associated with poor prognosis in prostate, colorectal, GISTs and glial tumors (25,(27)(28)(29)(30).…”
Section: Univariate Analysis Multivariate Analysismentioning
confidence: 99%
“…Noteworthy, RKIP has been shown to be a prognostic marker in prostate cancer, colorectal carcinomas, gliomas and GISTs (25,(27)(28)(29)(30).…”
Section: Introductionmentioning
confidence: 99%